Compare · LMNX vs SYK
LMNX vs SYK
Side-by-side comparison of Luminex Corporation (LMNX) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LMNX and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK carries a market cap of $126.60B.
- Over the past year, LMNX is down 19.2% and SYK is down 18.1% - SYK leads by 1.0 points.
- SYK has hit the wire 3 times in the past 4 weeks while LMNX has been quiet.
- SYK has more recent analyst coverage (25 ratings vs 0 for LMNX).
- Company
- Luminex Corporation
- Stryker Corporation
- Price
- $13.58-1.52%
- $330.37+3.52%
- Market cap
- -
- $126.60B
- 1M return
- +6.43%
- +5.30%
- 1Y return
- -19.17%
- -18.13%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2000
- News (4w)
- 0
- 3
- Recent ratings
- 0
- 25
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest LMNX
- SEC Form 15-12G filed by Luminex Corporation
- SEC Form 4: Eck Stephen L. returned $1,408,701 worth of Common Stock to the company (38,073 units at $37.00) , closing all direct ownership in the company (for withholding tax)
- SEC Form 4: ERICKSON THOMAS W returned $6,932,542 worth of Common Stock to the company (187,366 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: KEVER JIM D returned $8,517,363 worth of Common Stock to the company (230,199 units at $37.00) , closing all direct ownership in the company to satisfy withholding obligation
- SEC Form 4: Lewis Dijuana K returned $257,335 worth of Common Stock to the company (6,955 units at $37.00) , closing all direct ownership in the company
- SEC Form 4: MCNAMARA KEVIN M returned $3,713,616 worth of Common Stock to the company (100,368 units at $37.00) , closing all direct ownership in the company to cover withholding tax
- SEC Form 4: OGUNRO EDWARD A returned $2,253,041 worth of Common Stock to the company (60,893 units at $37.00) , closing all direct ownership in the company to cover taxes
- SEC Form 4: SAMET KENNETH A returned $733,229 worth of Common Stock to the company (19,817 units at $37.00) , closing all direct ownership in the company (withholding tax)
- SEC Form 4: Rew Richard W. II returned $1,760,312 worth of Common Stock to the company (47,576 units at $37.00) , closing all direct ownership in the company to satisfy withholding tax
- SEC Form 4: SHAMIR NACHUM returned $8,923,290 worth of Common Stock to the company (241,170 units at $37.00) , closing all direct ownership in the company to cover taxes
Latest SYK
- Stryker expands Mako robotics portfolio with full market release of Mako RPS
- BMO Capital Markets initiated coverage on Stryker with a new price target
- Stryker to announce second quarter 2026 financial results
- Stryker Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Stryker partners with professional golfer Shane Lowry to spotlight the caregiver journey in joint replacement
- Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
- President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)
- Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
- VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)
- Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)